Open Lung Strategy in Critically Ill Morbid Obese Patients



Status:Active, not recruiting
Conditions:Obesity Weight Loss, Cardiology, Cardiology, Hospital, Pulmonary
Therapuetic Areas:Cardiology / Vascular Diseases, Endocrinology, Pulmonary / Respiratory Diseases, Other
Healthy:No
Age Range:18 - Any
Updated:3/13/2019
Start Date:April 2016
End Date:June 30, 2020

Use our guide to learn which trials are right for you!

Open Lung Strategy in Critically Ill Morbid Obese Patients Lung Imaging and Heart-lung Interaction

The goal of this interventional crossover study in morbidly obese intubated and mechanically
ventilated patients is to describe the respiratory mechanics and the heart-lung interaction
at titrated positive end-expiratory pressure levels following a recruitment maneuver with
transthoracic echocardiography and electric impedance tomography imaging.

Obese patients under mechanical ventilation are more likely to develop atelectasis as a
consequence of the increased abdominal weight. Atelectasis is the primary responsible for
respiratory insufficiency and impossibility to wean obese patients from respiratory support.

In a previous study we demonstrated the efficacy of the application of titrated PEEP levels
following a recruitment maneuver in obese patients, i.e. improvement in respiratory mechanics
and gas exchanges without negative hemodynamic effects.

The application of lung and heat imaging will allow us to quantitatively describe:

- Increase in aerated lung tissue (reduction of atelectasis)

- Reduction of over-inflation of the ventilated regions

- Recoupling of ventilation and perfusion

- Improvement in right heart function by reduction of right heart afterload

Inclusion Criteria:

- ICU admitted requiring intubation and mechanical ventilation

- BMI ≥ 35 kg/m2

- Waist circumference > 88 cm (for women)

- Waist circumference > 102 cm (for men)

Exclusion Criteria:

- Known presence of esophageal varices

- Recent esophageal trauma or surgery

- Severe thrombocytopenia (Platelets count ≤ 5,000/mm3)

- Severe coagulopathy (INR ≥ 4)

- Presence or history of pneumothorax

- Pregnancy

- Patients with poor oxygenation index (PaO2/FiO2< 100 mmHg with at least 10 cmH2O of
PEEP)

- Pacemaker and/or internal cardiac defibrillator

- Hemodynamic parameters: systolic blood pressure (SBP) <100 mmHg and >180 mmHg, or if
SBP is between 100-180 mmHg on high dose of IV continuous infusion norepinephrine (>20
μg per minute), or dobutamine (>10 μg per minute), or dopamine (>10 μg per Kg per
minute), or epinephrine (>10 μg per minute).
We found this trial at
1
site
185 Cambridge Street
Boston, Massachusetts 02114
617-724-5200
?
mi
from
Boston, MA
Click here to add this to my saved trials